Compare MEDP & DRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space and cyber domains. The company is in the design, development and manufacture of Advanced sensing, network computing, force protection and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue and Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designs, develops and manufactures sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision making and execution by the customers.